Literature DB >> 34632412

Generation of an orthotopic mouse model to study colorectal cancer metastasis.

Liwen Zhang1,2, Pengcheng Bu1,2,3.   

Abstract

This protocol describes the generation of a mouse colorectal cancer (CRC) model to study the mechanism of CRC growth and metastasis. Compared to existing protocols, this protocol is mainly to improve the incidence of metastasis. The major advantage of this model is that it mimics the process of clinical CRC metastasis. Thus, it can be used to study different stages of CRC progression and to identify molecular markers or therapeutic targets. The limitation is the difficulty of performing the operation. For complete details on the use and execution of this protocol, please refer to Zhang et al. (2021).
© 2021 The Authors.

Entities:  

Keywords:  Cancer; Model Organisms

Mesh:

Year:  2021        PMID: 34632412      PMCID: PMC8488307          DOI: 10.1016/j.xpro.2021.100792

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Mouse maintenance and experimental procedures were approved by the Biomedical Research Ethics Committee of the Institute of Biophysics, Chinese Academy of Sciences. 6–8 weeks old female mice are used in this protocol.

Preparation of mouse surgery

Timing: 1 h Label and weigh the mice before surgery. Prepare a set of autoclaved and dried items for each mouse one day before surgery: 2 gauzes; 10 cotton swabs; 1 scissors; 2 forceps; 1 needle holders.

Preparation of cell suspension for orthotopic injection

Timing: 1 h, on the day for surgery. Prewarm PBS, 0.25% trypsin-EDTA and RPMI 1640 medium at water bath at 37°C before use. When HCT116, CRC57 or CT26 cells reach 70%–80% confluence in a 10 cm-dish, dissociate the cells using trypsin-EDTA. Recommend passage numbers less than 20. Transfer the cell suspension to a 15 mL polypropylene tube. Centrifuge the tube at 200 g for 3 min at 4°C. Aspirate supernatant and wash the cell pellet with 8 mL PBS and count the cells. Resuspend the cell pellet with PBS at 4×107 cells/mL and transfer to a 1.5 mL tube. Prepare at least 20% more injection volume in the case of the loss during resuspending the cells or with leakage during the injection. Inject 50 μL cell suspension per mouse. Keep the cell suspension on ice.

Key resources table

Materials and equipment

Store stock solution at 4°C for tribromoethanol for 1 year, and −20°C for bupivacaine and dexamethasone for 6 months.

Step-by-step method details

Setup surgical platform

Timing: 40 min Turn on UV light of the biological safety cabinet and sterile surgical platform for 30 min. Place heat pad in the middle of the cabinet. Turn on the heat by plugging into the outlet. Ensure it is working. Cover the heat pad with another sterile field piece and fix it using tape. Open autoclaved toolbox and lay out the tools onto sterile surgery field. CRITICAL: avoid touching them with contaminated gloves. Open suture and lay out it onto sterile surgery field. Prepare tubes with iodine and 70% ethanol. Place other required materials in the biological safety cabinet (Figure 1).
Figure 1

Surgical area

(A–L) (A) Sterile 1 mL syringe, (B) Tape, (C) Razor, (D) 70% ethanol, (E) Iodine, (F) Sterile gauze, (G) Forceps, (H) Scissors, (I) Sterile Cotton swabs, (J) 29-gauge insulin syringe, (K) Needle holders, (L) Suture (pre- autoclaved container)

Surgical area (A–L) (A) Sterile 1 mL syringe, (B) Tape, (C) Razor, (D) 70% ethanol, (E) Iodine, (F) Sterile gauze, (G) Forceps, (H) Scissors, (I) Sterile Cotton swabs, (J) 29-gauge insulin syringe, (K) Needle holders, (L) Suture (pre- autoclaved container)

Mouse setup

Timing: 10 min Prepare a spare cage for holding mice after surgery. Setup a heat pad for warming up the mouse cage. Half of the post-surgery cage should be placed on the heat pad, so mouse can warm up. Make sure heat pad is functional. Weigh the mouse. Anesthetize the mouse by intraperitoneal injection of 0.2 mL/10 g body weight tribromoethanol solution. Monitor respiratory and heart rate of the mouse. Assess level of anesthesia by pedal reflex (firm toe pinch). The mouse should fall asleep within 5 min. Transfer the mouse to the sterile platform above the heat pad. Fix the mouse in position by taping down the limbs. Apply the ophthalmic ointment to prevent retina damage.

Mouse surgery

Timing: 10 min Shave the mouse hair around the surgery site. Clean and sterilize the surgery area using sterile cotton swabs with iodine and 70% ethanol, consecutively. It should be done in a spiral motion, from the middle to the outside and the process should be repeated 3 times. Place sterile gauze around surgery site to prevent contamination (Figure 2).
Figure 2

Mice with sterile gauze, scale bar, 1.5 cm

Mice with sterile gauze, scale bar, 1.5 cm Subcutaneously inject the mouse with 100 μL 0.125% bupivacaine for analgesia. Using forceps and surgical scissors, open the outer skin layer. Make a smaller incision into the inner muscle layer (Figure 3).
Figure 3

Open the abdomen, scale bar, 1.6 cm

Open the abdomen, scale bar, 1.6 cm CRITICAL: avoid hurting blood vessels or organs. Identify and expose the cecum using forceps and cotton swabs. Do not use forceps to drag tissue. Cecum is usually located at the right side of stomach (Figure 4).
Figure 4

Cecum location, scale bar, 1.5 cm

If the cecum is dry, use 1 mL syringe with sterile saline to sustain tissue hydration. Withdraw 50 μL of the cell suspension with a 29-gauge insulin syringe. Keep the cell suspension on ice and mix upside down before injection. Fix the injection site by using cotton swabs. Do not injure vessels in submucosa of cecum or mesentery. Injection site should be between the blood vessels (Figure 5).
Figure 5

Cecum injection, scale bar, 1 cm

Cecum location, scale bar, 1.5 cm Gently insert the 29-gauge needle of the insulin syringe, approximately 1 mm, into the sub serosal layer. Face a needle tip upward and insert as shallow as possible. Slowly inject 50 μL of the cell suspension into the semitransparent sub serosal layer. Sub serosal swelling will be observed if injection is performed successfully. This procedure requires surgical skill and practice to obtain reproducible results. Check the injection site for leakage and bleeding (Kasashima et al., 2021). Use sterile suture and needle holder to close the inner muscle layer and the skin layer using discontinuous knots. Use Loctite 406 glue to close the skin over the suture, to prevent it breaking apart. Inject mouse with 50 μL/20 g mouse dexamethasone (at 0.1 mg/mL) to avoid surgery-caused inflammation. Put the mouse on heat pad. Record mouse data in record sheet found in surgery logbooks. Cecum injection, scale bar, 1 cm

After surgery

Timing: 4–6 weeks If more mice are being used, replace the sterile surgical tools onto sterile pad. Wait until mice recover from anesthesia. Put mice back and make sure that the mice have a water bottle and wet food. Inject mice with 50 μL dexamethasone every day for the next 3 days to avoid surgery-caused inflammation. Weigh the mice and assess their health until the experiment is finished.

Expected outcomes

In approximately 4–6 weeks the mice will be moribund. Sacrifice all mice to assess tumors in cecum and metastases in liver (Figures 6 and 7).
Figure 6

Tumors in cecum and liver, scale bar, 1 cm

Figure 7

Hematoxylin and eosin staining show metastatic tumors in liver (Zhang et al., 2021), scale bar, 0.3 cm

Tumors in cecum and liver, scale bar, 1 cm Hematoxylin and eosin staining show metastatic tumors in liver (Zhang et al., 2021), scale bar, 0.3 cm

Quantification and statistical analysis

Create an excel file to record data of each mouse. Data to be recorded should include sex, date of birth, age, and body weight before surgery, body weight at the endpoint. At the endpoint, weight of tumor, the number of liver metastases, photo of primary tumor and liver should be recorded.

Limitations

In addition to orthotopic CRC model, splenic injection and tail vein injection are used to study CRC metastasis as well. The advantage of orthotopic CRC model is that the model is to mimic human CRC development process and can study both primary CRC growth, invasion, and liver metastasis. The limitation of the model mainly lies in its difficulty for operation. If cecum injection leaks, tumor cell growth occurs intraperitoneally. Furthermore, the development of liver metastasis using orthotopic CRC model differs when different cell lines and mice strain are used. This model covers most stages of human tumor growth and metastasis, including primary tumor growth, invasion, and liver metastasis, similar to CRC progression in patients. In our experiments, ten out of ten mice developed liver metastasis when CRC57 or HCT116 were injected, while four out of ten mice had liver metastasis when CT26 were injected, ten out of ten mice that die from tumors develop liver metastases. The main reason for the high metastasis rate compared to other models is the different microenvironment of tumor growth.

Troubleshooting

Problem 1

Can’t find cecum (Step 18).

Potential solution

Open abdomen at bottom right (Figure 4).

Problem 2

Leakage from the injection site (step 22). Inject cell suspension as slowly as possible and hold the syringe for a while. If still leakage, reduce the injection volume may help.

Problem 3

Sub-serosal swelling in cecum cannot be seen (step 22). Cecum injection is too deep. Face a needle tip upwards and insert as shallowly as possible (Kasashima et al., 2021).

Problem 4

Mice die of infection several days after the surgery (step 32). Because NCG mice are severely immunodeficient, whole process must be strictly sterilized.

Problem 5

No metastases are observed (step 32). Sacrifice mice too early. Make sure most mice got moribund before sacrifice. Make sure the cells are well cultured and haven’t been passaged too many times.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Pengcheng Bu (bupc@ibp.ac.cn).

Materials availability

This study did not generate new materials.
REAGENT or RESOURCESOURCEIDENTIFIER
Chemicals, peptides, and recombinant proteins

PBS (no calcium, no magnesium)Thermo Fisher ScientificCat# 10010023
Trypsin-EDTA (0.25%), phenol redGibcoCat# 25200072
RPMI 1640 mediumGibcoCat# C11875500BT
TribromoethanolSigmaCat# T48402
BupivacaineADAMASCat# 23486A
DexamethasoneSigmaCat# D4902
70% EthanolMintN/A
IodineMintN/A
Sterile salineSHIMENN/A
Tert-amyl alcoholSigmaCat# 152463

Experimental models: Cell lines

HCT116ATCCCat# CCL-247
CRC57Gift form David Hsu at Duke UniversityN/A
CT26ATCCCat# CRL-2638

Experimental models: Organisms/strains

Mouse: NCGGemPharmatechCat# T001475
Mouse: BALB/cGemPharmatechCat# N000020

Other

15 mL Polypropylene tubeCorningCat# 430052
ScissorsSanyouCat# 042000
ForcepsSanyouCat# 044570
Needle holdersSanyouCat# 014014
Cotton swabsN/AN/A
Suture (pre-autoclaved container)Jinhuan MedicalCat# CR631
Autoclave bagMedicomCat# 88025
TapeDeliCat# 30670
Heat padN/AN/A
Insulin syringe, 29 gaugeBDCat# 328421
Loctite 406 glueN/AN/A
ReagentFinal concentrationStock concentrationAmount
Tribromoethanol0.02 g/mL in sterile saline1.6 g/mL in Tert-amyl alcohol0.2 mL/10g body weight
Bupivacaine0.00125 g/mL in sterile saline0.0084 g/mL in sterile saline100 μL per mouse
Dexamethasone0.1 mg/mL in sterile PBS1 mg/mL in sterile PBS50 μL/20 g body weight

Store stock solution at 4°C for tribromoethanol for 1 year, and −20°C for bupivacaine and dexamethasone for 6 months.

  2 in total

1.  Creatine promotes cancer metastasis through activation of Smad2/3.

Authors:  Liwen Zhang; Zijing Zhu; Huiwen Yan; Wen Wang; Zhenzhen Wu; Fei Zhang; Qixiang Zhang; Guizhi Shi; Junfeng Du; Huiyun Cai; Xuanxuan Zhang; David Hsu; Pu Gao; Hai-Long Piao; Gang Chen; Pengcheng Bu
Journal:  Cell Metab       Date:  2021-04-02       Impact factor: 27.287

2.  Mouse model of colorectal cancer: orthotopic co-implantation of tumor and stroma cells in cecum and rectum.

Authors:  Hiroaki Kasashima; Angeles Duran; Tania Cid-Diaz; Yu Muta; Hiroto Kinoshita; Eduard Batlle; Maria T Diaz-Meco; Jorge Moscat
Journal:  STAR Protoc       Date:  2021-01-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.